Confronting cancer at its molecular level 26 to 28 June, Sofitel Bercy, Paris France
A new generation of diagnosis, the ability of treating cancer at its earliest stage: promises of nanotechnology in oncology are high.
Indeed there was not so much modification in treatment efficacy from the 50th. The only way to know if therapy has been efficient is to wait wether it reappears. The fact is that diagnostic is too late and histological diagnosis is not indicative of prognosis and therapeutical response prediction...
details http://www.upperside.fr/cancernano2007/nanocancer2007intro.htm
